Wellington Management Group LLP Reata Pharmaceuticals Inc Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $4.03 Million - $5.36 Million	50,881 Added 3.58%	1,472,043 $150 Million
Q1 2023 May 12, 2023	SELL	$30.85 - $93.17 $2.68 Million - $8.08 Million	-86,720 Reduced 5.75%	1,421,162 $129 Million
Q4 2022 Feb 13, 2023	SELL	$22.15 - $42.11 $1.43 Million - $2.71 Million	-64,384 Reduced 4.09%	1,507,882 $57.3 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $47.3 Million - $88.9 Million	-2,437,394 Reduced 60.79%	1,572,266 $39.5 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $8.01 Million - $14.1 Million	-386,879 Reduced 8.8%	4,009,660 $122 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $3.46 Million - $5.69 Million	143,562 Added 3.38%	4,396,539 $144 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $110.96 $248,545 - $1.08 Million	9,705 Added 0.23%	4,252,977 $112 Million
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $8.32 Million - $11.9 Million	-83,196 Reduced 1.92%	4,243,272 $427 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $2.29 Million - $4.43 Million	-29,299 Reduced 0.67%	4,326,468 $612 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $946,552 - $1.33 Million	10,043 Added 0.23%	4,355,767 $434 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $36.3 Million - $65.7 Million	355,972 Added 8.92%	4,345,724 $537 Million
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $23.2 Million - $40.5 Million	248,053 Added 6.63%	3,989,752 $389 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $91 Million - $127 Million	720,775 Added 23.86%	3,741,699 $584 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $78 Million - $156 Million	628,250 Added 26.26%	3,020,924 $436 Million
Q4 2019 Feb 11, 2020	BUY	$74.57 - $217.92 $178 Million - $521 Million	2,392,674 New	2,392,674 $489 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account